Pharmaceutical Formulations: Ready For Patenting?

Law360, New York (December 20, 2016, 5:35 PM EST) -- Colleen Tracy James

Ying-Zi Yang Pharmaceutical companies are increasingly combining forces through research and collaboration agreements. It is critical to ensure that as companies negotiate and enter into these agreements, they do not inadvertently create an on-sale bar. The on-sale bar doctrine may be triggered if an invention was "on sale" and "ready for patenting" one year before the effective filing date. To minimize the risk of an on-sale bar or a public use bar, a patent application should also be filed — at the latest — within one year of the date that an invention is ready for patenting, i.e.,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!